Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation

Abstract

The short arm of chromosome 8, 8p, is often rearranged in carcinomas, typically showing distal loss by unbalanced translocation. We analysed 8p rearrangements in 48 breast, pancreatic and colon cancer cell lines by fluorescence in situ hybridization (FISH) and array comparative genomic hybridization, with a tiling path of 0.2 Mb resolution over 8p12 and 1 Mb resolution over chromosome 8. Selected breast lines (MDA-MB-134, MDA-MB-175, MDA-MB-361, T-47D and ZR-75-1) were analysed further. Most cell lines showed loss of 8p distal to a break that was between 31 Mb (5′ to NRG1) and the centromere, but the translocations were accompanied by variable amplifications, deletions and inversions proximal to this break. The 8p12 translocation in T-47D was flanked by an inversion of 4 Mb, with a 100 kb deletion at the proximal end. The dicentric t(8;11) in ZR-75-1 carries multiple rearrangements including interstitial deletions, a triplicated translocation junction between NRG1 and a fragment of 11q (unconnected to CCND1), and two separate amplifications, of FGFR1 and CCND1 . We conclude that if there is a tumour suppressor gene on 8p it may be near 31 Mb, for example WRN; but the complexity of 8p rearrangements suggests that they target various genes proximal to 31 Mb including NRG1 and the amplicon centred around ZNF703/FLJ14299.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abdel-Rahman WM, Katsura K, Rens W, Gorman PA, Sheer D, Bicknell D et al. (2001). Proc Natl Acad Sci USA 98: 2538–2543.

  • Adams J, Williams SV, Aveyard JS, Knowles MA . (2005). Cancer Res 65: 66–75.

  • Adelaide J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ et al. (2003). Genes Chromosomes Cancer 37: 333–345.

  • Alsop AE, Teschendorff A, Edwards PA . (2006). Cancer Genet Cytogenet 164: 97–109.

  • Arakawa H . (2004). Nat Rev Cancer 4: 978–987.

  • Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR et al. (2005). Cancer Res 65: 1164–1173.

  • Bautista S, Theillet C . (1998). Genes Chromosomes Cancer 22: 268–277.

  • Bernardino J, Apiou F, Gerbault-Seureau M, Malfoy B, Dutrillaux B . (1998). Genes Chromosomes Cancer 23: 100–108.

  • Birnbaum D, Adelaide J, Popovici C, Charafe-Jauffret E, Mozziconacci MJ, Chaffanet M . (2003). Lancet Oncol 4: 639–642.

  • Courtay-Cahen C, Morris JS, Edwards PA . (2000). Genomics 66: 15–25.

  • Davidson JM, Gorringe KL, Chin SF, Orsetti B, Besret C, Courtay-Cahen C et al. (2000). Br J Cancer 83: 1309–1317.

  • Dib A, Adelaide J, Chaffanet M, Imbert A, Le Paslier D, Jacquemier J et al. (1995). Oncogene 10: 995–1001.

  • Douglas EJ, Fiegler H, Rowan A, Halford S, Bicknell DC, Bodmer WF et al. (2004). Cancer Res 64: 4817–4825.

  • Dutrillaux B . (1995). Adv Cancer Res 67: 59–82.

  • Fiegler H, Carr P, Douglas EJ, Burford DC, Hunt S, Scott CE et al. (2003). Genes Chromosomes Cancer 36: 361–374.

  • Garcia MJ, Pole JC, Chin SF, Teschendorff A, Naderi A, Ozdag H et al. (2005). Oncogene 24: 5235–5245.

  • Gribble SM, Prigmore E, Burford DC, Porter KM, Ng BL, Douglas EJ et al. (2005). J Med Genet 42: 8–16.

  • Guan XY, Meltzer PS, Dalton WS, Trent JM . (1994). Nat Genet 8: 155–161.

  • Hinck L . (2004). Dev Cell 7: 783–793.

  • Huang HE, Chin SF, Ginestier C, Bardou VJ, Adelaide J, Iyer NG et al. (2004). Cancer Res 64: 6840–6844.

  • Hurst CD, Fiegler H, Carr P, Williams SV, Carter NP, Knowles MA . (2004). Oncogene 23: 2250–2263.

  • Hwang ES, DeVries S, Chew KL, Moore II DH, Kerlikowske K, Thor A et al. (2004). Clin Cancer Res 10: 5160–5167.

  • Karan D, Lin MF, Johansson SL, Batra SK . (2003). Int J Cancer 103: 285–293.

  • Klaus M, Schnittger S, Haferlach T, Dreyling M, Hiddemann W, Schoch C . (2003). Cancer Genet Cytogenet 144: 36–43.

  • Krane IM, Leder P . (1996). Oncogene 12: 1781–1788.

  • Lemieux N, Apiou F, Vogt N, Malfoy B, Dutrillaux B . (1996). Cancer Genet Cytogenet 90: 75–79.

  • Liu X, Baker E, Eyre HJ, Sutherland GR, Zhou M . (1999). Oncogene 18: 7110–7114.

  • Mann SM, Burkin DJ, Grin DK, Ferguson-Smith MA . (1997). Chromosome Res 5: 145–147.

  • Margolin AA, Greshock J, Naylor TL, Mosse Y, Maris JM, Bignell G et al. (2005). Bioinformatics 21: 3308–3311.

  • Morris JS, Carter NP, Ferguson-Smith MA, Edwards PA . (1997). Genes Chromosomes Cancer 20: 120–139.

  • Nakao K, Mehta KR, Fridlyand J, Moore DH, Jain AN, Lafuente A et al. (2004). Carcinogenesis 25: 1345–1357.

  • Orsetti B, Nugoli M, Cervera N, Lasorsa L, Chuchana P, Ursule L et al. (2004). Cancer Res 64: 6453–6460.

  • Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J et al. (2003). Am J Pathol 162: 763–770.

  • Prentice LM, Shadeo A, Lestou VS, Miller MA, Deleeuw RJ, Makretsov N et al. (2005). Oncogene 24: 7281–7289.

  • Ray ME, Yang ZQ, Albertson DG, Kleer CG, Washburn JG, Macoska JA et al. (2004). Cancer Res 64: 40–47.

  • Rousseau-Merck MF, Versteege I, Legrand I, Couturier J, Mairal A, Delattre O et al. (1999). Cancer Res 59: 3152–3156.

  • Schaefer G, Fitzpatrick VD, Sliwkowski MX . (1997). Oncogene 15: 1385–1394.

  • Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A et al. (2000). Blood 95: 738–743.

  • Sirivatanauksorn V, Sirivatanauksorn Y, Gorman PA, Davidson JM, Sheer D, Moore PS et al. (2001). Int J Cancer 91: 350–358.

  • Teixeira MR, Pandis N, Heim S . (2002). Genes Chromosomes Cancer 33: 1–16.

  • Theillet C, Adelaide J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J et al. (1993). Genes Chromosomes Cancer 7: 219–226.

  • Toomes C, Jackson A, Maguire K, Wood J, Gollin S, Ishwad C et al. (2003). Genes Chromosomes Cancer 37: 132–140.

  • Ugolini F, Adelaide J, Charafe-Jauffret E, Nguyen C, Jacquemier J, Jordan B et al. (1999). Oncogene 18: 1903–1910.

  • van den Engh G, Sachs R, Trask BJ . (1992). Science 257: 1410–1412.

  • Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B et al. (2001). Genes Chromosomes Cancer 30: 274–282.

  • Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S et al. (2003). Cancer Res 63: 2872–2880.

  • Volik S, Zhao S, Chin K, Brebner JH, Herndon DR, Tao Q et al. (2003). Proc Natl Acad Sci USA 100: 7696–7701.

  • Wang XZ, Jolicoeur EM, Conte N, Chaffanet M, Zhang Y, Mozziconacci MJ et al. (1999). Oncogene 18: 5718–5721.

Download references

Acknowledgements

We thank Huai-En Huang, Rachel Lyman, Nicholas J Roberts, Joanne M Staines, Melody Tabiner, and Katherine Williams for contributing to the FISH data and cell culture. Supported by Cancer Research UK, Biotechnology and Biological Sciences Research Council (BBSRC), Breast Cancer Campaign, Wellbeing, Medical Research Council (studentship for SLC), Cambridge Commonwealth Trust (studentships for AEA, KAB) and Sackler Fund (KAB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P A W Edwards.

Additional information

Note:

Further analysis of 8p12 amplicons was recently published by Gelsi-Boyer et al., 2005. Mole Cancer Res.

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pole, J., Courtay-Cahen, C., Garcia, M. et al. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation. Oncogene 25, 5693–5706 (2006). https://doi.org/10.1038/sj.onc.1209570

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209570

Keywords

This article is cited by

Search

Quick links